Vincent Masekesa
Ask VT AI
View News Summary
- British cyclists dominate UCI Track Worlds with Madison gold and one-two pursuit finish.
- Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a platform for delivering RNA therapeutics to muscle tissue.
- Controversial Israeli bills aim to halt Netanyahu's trial and block Bennett's election bid, sparking concerns over democracy and rule of law.
20 hours

United States Politics
Discover the latest news, candidates, and key topics of US politics
Ask VT AI
View News Summary
- British cyclists dominate UCI Track Worlds with Madison gold and one-two pursuit finish.
- Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a platform for delivering RNA therapeutics to muscle tissue.
- Controversial Israeli bills aim to halt Netanyahu's trial and block Bennett's election bid, sparking concerns over democracy and rule of law.
20 hours

United States Politics
Discover the latest news, candidates, and key topics of US politics
Most Reported By
News from Vincent Masekesa
News from Vincent Masekesa
